{"id":"W2000227671","doi":"10.1016/j.ijrobp.2014.08.206","title":"Nivolumab (Anti-PD-1; BMS-936558, ONO-4538) Maintenance as Monotherapy or in Combination With Bevacizumab (BEV) for Non-Small Cell Lung Cancer (NSCLC) Previously Treated With Chemotherapy","year":2014,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Nivolumab; Bevacizumab; Oncology; non-small cell lung cancer (NSCLC); Chemotherapy; Internal medicine; Lung cancer; Immunotherapy; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002297129,0.0003207995,0.0009829529,0.000351811,0.0003162813,0.0005714282,0.0004660917,0.0003195413,0.002811773],"category_scores_gemma":[0.000286587,0.0001388471,0.0004922215,0.0004130623,0.0002340851,0.0004054189,0.0001971775,0.0009694212,0.0005946686],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006268298,"about_ca_system_score_gemma":0.0007942104,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001722221,"about_ca_topic_score_gemma":0.006880434,"domain_scores_codex":[0.9998643,0.0000214036,0.000008355385,0.00002922536,0.00001629465,0.00006030795],"domain_scores_gemma":[0.9999129,0.00001148203,0.00001137242,0.000007664004,0.000005529395,0.00005112512],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1480239,0.01234052,0.01554992,0.001046725,0.001288812,0.0009072467,0.0003582406,0.003127016,0.2289616,0.001266904,0.01242181,0.5747072],"study_design_scores_gemma":[0.09826906,0.3904183,0.184077,0.0003765568,0.003699272,0.006966193,0.0006859287,0.01285209,0.2007383,0.002201775,0.0994418,0.000273877],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9880889,0.004681156,0.0003438027,0.0002233992,0.0002170794,0.0002250942,0.0004774111,0.0001600457,0.005583109],"genre_scores_gemma":[0.9943165,0.001452795,0.0007967331,0.000117097,0.00005848385,0.0001210819,0.0006488476,0.00001936145,0.002469133],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002811773,"threshold_uncertainty_score":0.009406269,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01147262402719408,"score_gpt":0.3019271566340644,"score_spread":0.2904545326068703,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}